Announcements
- $5.7m Milestone Monetization Agreement with AOP
- Results of 2024 Annual General Meeting
- New Drug Application for Accrufer® in South Korea
- Audited results for the year ended 31 Dec 2023
- Business Update for Q1 2024
- Notice of Results
- Unaudited Full Year Trading Update
- Appointment of new Chief Financial Officer
- Q3 2023 U.S. Commercial Highlights
- PDMR Transaction Notification
More ▼
Key statistics
On Friday, Shield Therapeutics PLC (1JS:DEU) closed at 0.024, 140.00% above the 52 week low of 0.01 set on Apr 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.019 |
---|---|
High | 0.027 |
Low | 0.019 |
Bid | 0.0145 |
Offer | 0.0235 |
Previous close | 0.02 |
Average volume | 7.50k |
---|---|
Shares outstanding | 782.06m |
Free float | 293.18m |
P/E (TTM) | -- |
Market cap | 12.51m GBP |
EPS (TTM) | -0.0458 GBP |
Data delayed at least 15 minutes, as of Jul 19 2024.
More ▼